NCT06071052 2026-03-05
DREAM
First Affiliated Hospital, Sun Yat-Sen University
Phase 2 Completed
Clinical Trials
9 trialsNCT05175092 2026-02-06
Living Donor Liver Transplantation for CRC Liver Metastases
University of Wisconsin, Madison
Phase NA Withdrawn
NCT06199232 2026-01-28
Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment
Peking University
Phase NA Active not recruiting
NCT06935149 2025-04-24
PSMA
Primo Biotechnology Co., Ltd
Phase 1 Not yet recruiting
NCT04798898 2024-12-05
ISCOLIM
University of Aarhus
Phase NA Recruiting
NCT06047015 2024-08-09
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
University of Saskatchewan
Phase 1/2 Not yet recruiting
NCT04832776 2021-04-06
FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
Fudan University
Phase 2 Unknown
NCT04003792 2020-10-20
Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.
Rabin Medical Center
Phase 2 Unknown
NCT03444194 2018-02-23
TRICOMA
Odense University Hospital
Phase NA Unknown